Index of reports
> Disability (2)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Emsam (Selegiline Transdermal) disability. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Emsam side effects in 46 year old female
Reported by a physician from United States on 2012-03-29
Patient: 46 year old female, weighing 54.4 kg (119.7 pounds)
Reactions: Tenosynovitis
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Emsam
Dosage: changed qd.
Indication: Depression
Start date: 2007-10-01
End date: 2008-04-01
Emsam
Dosage: changed qd.
Start date: 2008-06-01
End date: 2010-06-01
Emsam
Dosage: changed qd.
Start date: 2011-03-01
End date: 2011-06-01
Other drugs received by patient: Sonata; Trazodone HCL; Acyclovir
Possible Emsam side effects in 49 year old male
Reported by a consumer/non-health professional from United States on 2012-01-04
Patient: 49 year old male, weighing 117.9 kg (259.4 pounds)
Reactions: Overdose, Incorrect Dose Administered, Product Adhesion Issue
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Emsam
|